Список проголосовавших за комментарий " On The Wires<ul><li>Icahn Enterprises L.P. (<strong>IEP</strong>) announced it has extended the expiration of its cash tender offer, through its indirect wholly owned subsidiary, IEH FM Holdings LLC, to acquire all of the outstanding shares of common stock of Federal-Mogul Holdings Corporation (<strong>FDML</strong>) not already owned by IEH or its affiliates to 12:00 midnight, New York City time, on January 18, 2017 (one minute after 11:59 P.M., New York City time, on January 18, 2017) in order to give certain shareholders who have advised it that they intended, but were unable, to tender their Shares prior to the deadline an opportunity to do so. No increase of the offer price will be made under any circumstances.</li><li>MagneGas Corporation (<strong>MNGA</strong>) announced that it has expanded its product offering to include the commercial sale of Carbon Dioxide (CO2) in Florida.<br/> The Company will initially add CO2 to its industrial gas line of products in the Sarasota and Ft Myers areas of Florida, with plans to expand into other retail locations in the state in the coming months.</li><li>Delcath Systems, Inc. (<strong>DCTH</strong>) announced that new data from a retrospective study of Melphalan/HDS, entitled «Percutaneous Hepatic Perfusion For Unresectable Metastatic Ocular Melanoma To The Liver: A Multi-Institutional Report Of Outcomes,» has been accepted for oral presentation at the Regional Cancer Therapies 12th International Symposium, taking place February 18 — 20, 2017 at the Snowbird Ski and Summer Resort in Snowbird, UT.</li><li>Abbott (<strong>ABT</strong>) announced the European launch of the new Proclaim DRG Neurostimulation System, designed to deliver dorsal root ganglion (DRG) stimulation to patients suffering from chronic neuropathic pain. Through the Proclaim platform's Bluetooth wireless technology and iOS software, the Proclaim DRG Neurostimulation System offers patients a more intuitive therapy experience, compared to current systems with traditional controllers that can be difficult to operate. This new system will improve the experience of how patients interact with their device, which may lead more patients to consider DRG stimulation for the treatment of chronic neuropathic pain.</li><li>IBM (<strong>IBM</strong>) announced that the U.S. Army has signed a five-year, multi-million dollar contract with IBM to build, manage and operate a cloud solution for greater IT flexibility, efficiency and performance.</li><li>Daiichi Sankyo Company, Limited (<strong>DSNKY</strong>) announced the initiation of a three-part open-label phase 1/2 study in Japan with U3-1402, a novel HER3-targeting antibody drug conjugate, in patients with HER3-positive metastatic or unresectable breast cancer who are refractory or intolerant to standard treatment, or for whom no standard treatment is available.</li><li>Renewable Energy Systems (<strong>RES</strong>) announced substantial completion of the Bluestem Wind Project located in Beaver County, Oklahoma. The project, which consists of 60 Vestas V117-3.3 MW turbines, will distribute power via OG&E's transmission system, feeding the grids of cities and industries across the state, in addition to the broader Southwest Power Pool region. The project is expected to generate approximately 845,000 MWh per year, enough electricity to power 77,000 U.S. homes.</li><li>Quest Diagnostics (<strong>DGX</strong>) announced the launch of a new test service that helps physicians evaluate a patient's response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is significant because it may help physicians tailor more effective treatments for the up to 2.2 million individuals infected with HBV.</li><li>IBM (<strong>IBM</strong>) announced that the U.S. Army has signed a five-year, multi-million dollar contract with IBM to build, manage and operate a cloud solution for greater IT flexibility, efficiency and performance.</li><li>Eisai (<strong>ESALY</strong>) the U.S. pharmaceutical subsidiary of Eisai Co., announced today that it is participating in Access Accelerated, a global partnership to advance access to non-communicable diseases prevention, treatment and care in low and lower-middle income countries.</li><li>The EnLink Midstream companies, EnLink Midstream Partners, LP (<strong>ENLK</strong>) and EnLink Midstream, LLC (<strong>ENLC</strong>), will hold a conference call to discuss fourth quarter, full-year 2016 financial results and 2017 Guidance on Wednesday, February 15, at 9 a.m. Central time.</li><li>TD Bank Group announced that it expects TD Ameritrade's (<strong>AMTD</strong>) first quarter earnings to translate into a contribution of approximately CAD$111 million to fiscal 2017 first quarter net income for the Bank, which will be reported under International Financial Reporting Standards.</li></ul>"